虫垂炎診断と治療市場レポート：2030年までの動向、予測、競合分析

虫垂炎診断と治療の動向と予測

世界の虫垂炎診断と治療市場は、2024年から2030年までのCAGRが7.1%で、2030年までに推定140億米ドルに達すると予測されます。この市場の主な促進要因は、虫垂炎と小児虫垂炎の有病率の増加、虫垂炎に対する意識の高まり、世界全体のヘルスケア支出の増加です。世界の虫垂炎診断と治療市場の将来は、病院、診療所、画像診断センター市場におけるビジネスチャンスで有望視されています。

虫垂炎診断と治療市場の洞察

急性虫垂炎は、数時間から数日の間に急速に発症する虫垂の炎症を特徴とするため、予測期間中に高い成長が見込まれるとLucintelは予測しています。

この市場では、病院と診療所が最大のセグメントであり続けると思われます。

北米は虫垂炎の有病率が高く、人々の間でこの病気に対する認識が高まっているため、予測期間中も最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答する：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.今後成長が加速するセグメントとその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の虫垂炎診断と治療市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の虫垂炎診断と治療市場動向（2018-2023）および予測（2024-2030）
• タイプ別の世界の虫垂炎診断と治療市場
  • 急性
  • 慢性
• 診断治療別の世界の虫垂炎診断と治療市場
  • 診断
  • 治療
• 最終用途別の世界の虫垂炎診断と治療市場
  • 病院
  • クリニック
  • 画像診断センター

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の虫垂炎診断と治療市場
• 北米の虫垂炎診断と治療市場
• 欧州の虫垂炎診断と治療市場
• アジア太平洋虫垂炎診断と治療市場
• その他地域虫垂炎診断と治療市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の虫垂炎診断と治療市場の成長機会
  • 診断治療別の世界の虫垂炎診断と治療市場の成長機会
  • 最終用途別の世界の虫垂炎診断と治療市場の成長機会
  • 地域別の世界の虫垂炎診断と治療市場の成長機会
• 世界の虫垂炎診断と治療市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の虫垂炎診断と治療市場の能力拡大
  • 世界の虫垂炎診断と治療市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Johnshon & Johnshon
• Pfizer
• Lupin
• Siemens
• Medtronic
• Cook
• Teva Pharmaceutical industries

Appendicitis Diagnostics and Treatment Trends and Forecast

The future of the global appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets. The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

A more than 150-page report is developed to help in your business decisions.

Appendicitis Diagnostics and Treatment by Segment

The study includes a forecast for the global appendicitis diagnostics and treatment by type, diagnosis treatment, end use, and region.

Appendicitis Diagnostics and Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Acute
• Chronic

Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Diagnosis
• Treatment

Appendicitis Diagnostics and Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Diagnostic Imaging Centers

Appendicitis Diagnostics and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Appendicitis Diagnostics and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies appendicitis diagnostics and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the appendicitis diagnostics and treatment companies profiled in this report include-

• Johnshon & Johnshon
• Pfizer
• Lupin
• Siemens
• Medtronic
• Cook
• Teva Pharmaceutical Industries

Appendicitis Diagnostics and Treatment Market Insights

Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Within this market, hospitals & clinics will remain the largest segment.

North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Features of the Global Appendicitis Diagnostics and Treatment Market

Market Size Estimates: Appendicitis diagnostics and treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Appendicitis diagnostics and treatment market size by type, diagnosis treatment, end use, and region in terms of value ($B).

Regional Analysis: Appendicitis diagnostics and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis treatments, end uses, and regions for the appendicitis diagnostics and treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the appendicitis diagnostics and treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the appendicitis diagnostics and treatment market size?

Answer: The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030.

Q.2 What is the growth forecast for appendicitis diagnostics and treatment market?

Answer: The global appendicitis diagnostics and treatment market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the appendicitis diagnostics and treatment market?

Answer: The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.

Q4. What are the major segments for appendicitis diagnostics and treatment market?

Answer: The future of the appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets.

Q5. Who are the key appendicitis diagnostics and treatment market companies?

Answer: Some of the key appendicitis diagnostics and treatment companies are as follows:

• Johnshon & Johnshon
• Pfizer
• Lupin
• Siemens
• Medtronic
• Cook
• Teva Pharmaceutical Industries

Q6. Which appendicitis diagnostics and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that acute appendicitis is expected to witness higher growth over the forecast period as it is characterized by inflammation of the appendix that develops rapidly, over a period of hours or days.

Q7. In appendicitis diagnostics and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of appendicitis and increasing awareness of the disease among people.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the appendicitis diagnostics and treatment market by type (acute and chronic), diagnosis treatment (diagnosis and treatment), end use (hospitals, clinics, and diagnostic imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Appendicitis Diagnostics and Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Appendicitis Diagnostics and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Appendicitis Diagnostics and Treatment Market by Type
  • 3.3.1: Acute
  • 3.3.2: Chronic
• 3.4: Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
  • 3.4.1: Diagnosis
  • 3.4.2: Treatment
• 3.5: Global Appendicitis Diagnostics and Treatment Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Diagnostic Imaging Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Appendicitis Diagnostics and Treatment Market by Region
• 4.2: North American Appendicitis Diagnostics and Treatment Market
  • 4.2.2: North American Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
• 4.3: European Appendicitis Diagnostics and Treatment Market
  • 4.3.1: European Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
  • 4.3.2: European Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
• 4.4: APAC Appendicitis Diagnostics and Treatment Market
  • 4.4.1: APAC Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
  • 4.4.2: APAC Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers
• 4.5: ROW Appendicitis Diagnostics and Treatment Market
  • 4.5.1: ROW Appendicitis Diagnostics and Treatment Market by Type: Acute and Chronic
  • 4.5.2: ROW Appendicitis Diagnostics and Treatment Market by End Use: Hospitals, Clinics, and Diagnostic Imaging Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Type
  • 6.1.2: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Diagnosis Treatment
  • 6.1.3: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by End Use
  • 6.1.4: Growth Opportunities for the Global Appendicitis Diagnostics and Treatment Market by Region
• 6.2: Emerging Trends in the Global Appendicitis Diagnostics and Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Appendicitis Diagnostics and Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Appendicitis Diagnostics and Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Johnshon & Johnshon
• 7.2: Pfizer
• 7.3: Lupin
• 7.4: Siemens
• 7.5: Medtronic
• 7.6: Cook
• 7.7: Teva Pharmaceutical industries